MSDand Samsung Bioepis enter collaboration agreement to develop and commercialize insulin glargine candidate for diabetes
11 February 2014 | By Merck
MSD and Samsung Bioepis Co., Ltd., announced that they have expanded their collaboration with an agreement to develop, manufacture and commercialize MK-1293...